QC Kinetix, a Charlotte-based regenerative medicine provider, is restructuring its approach to support existing franchisees following significant declines in unit counts and systemwide revenue. The company treats musculoskeletal pain and joint issues related to injuries, arthritis, and chronic conditions.
Peter Holt assumed the role of chief executive officer in April. He brings experience from a previous turnaround at The Joint Chiropractic, where he helped expand the network from under 300 locations to nearly 1,000 during his tenure starting in 2016. His strategy there emphasized franchisee relationships and unit economics.
QC Kinetix experienced rapid initial expansion, growing from its 2020 launch to 169 clinics by 2022. However, the system later faced performance challenges. The brand finished 2025 with 110 locations, a drop from 167 at the start of that year. Systemwide sales also fell sharply, dropping from $157 million in 2023 to $112 million in 2024, and an estimated $101.6 million in 2025.
Holt attributed part of the struggle to a marketing strategy that relied heavily on talk radio and television. He noted that this approach became less effective as the market evolved and competition increased. The previous model required franchisees to spend millions educating consumers, but changing macroeconomic conditions reduced its impact.
The company is now shifting toward digital marketing and using patient data to better target prospective customers. Holt indicated that the earlier reliance on traditional media missed opportunities to reach women, who represent a large portion of the regenerative medicine market.
